In addition, YFJP maintained high percentages of CD3+ and CD8+ T cells in peripheral blood, spleen and tumor tissues, while reducing the expression of multiple inhibitory receptors on CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.